Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pharmacology Study of Final Formulation of FYU-981 Administered to Healthy Male Adults

NCT03350373 is registered in ClinicalTrials.gov with Mochida Pharmaceutical Company, Ltd. as lead sponsor.

NCT NCT03350373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pharmacology Study of Final Formulation of FYU-981 Administered to Healthy Male Adults
Lead sponsor
Mochida Pharmaceutical Company, Ltd.
Phase
Phase 1
Overall status
Completed
Start date
November 6, 2017
Completion date
November 29, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy